We Screen Biotech Companies then Predict the Breakout

On July 5th, 2025, we screened 640 biotechnology companies to detect financial signals that often precede significant price movement. The filters results follow:

1,195

Cash Runway Risk

1,092

High R&D to Revenue

913

Revenue Growth Acceleration

823

Revenue Spike ≥20%

610

Net Income Breakout

610

Loss Reversal

Each flag represents a measurable change in fundamentals that may indicate an emerging catalyst. Companies are ranked by how many of these indicators they’ve triggered and how rare each signal is relative to their peers. This process allows us to focus on the most promising candidates for deeper analysis and prediction.

ScanScor is built to forecast potential breakouts across the entire biomedical industry. We have designed a system to keep news and data up to date for all tracked companies, enabling us to run fresh predictions as new catalysts emerge. Look for ScanScor reports highlighting companies with approaching catalyst dates and the potential for significant moves.

🚀 See what the AI behind ScanScor thinks about our highest-ranked stocks.
View the Reports Listings Page
BPE Predictions TODAY
0
We Recently Activated Orbo and the BPE
BPE Predictions this Week
73
Last 5 trading days
BPE Predictions this Month
124
Last 21 trading days
Ttl Unique Tickers
1388
BioPharma Stocks Ranked and Queued for Prediction
Total AI Stock Analysis Sessions Recorded
1407
AI is smarter with every report
Scroll to Top